Cutler Group LP Prometheus Biosciences, Inc. Call Options Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 01, 2023
SELL
$103.46 - $126.29 $1.12 Million - $1.36 Million
-10,800 Reduced 73.47%
3,900 $10,000
Q4 2022

Feb 07, 2023
BUY
$36.06 - $117.21 $530,082 - $1.72 Million
14,700 New
14,700 $106,000
Q1 2022

Apr 14, 2022
SELL
$30.13 - $50.0 $512,210 - $850,000
-17,000 Closed
0 $0
Q4 2021

Jan 18, 2022
BUY
$22.28 - $39.54 $378,760 - $672,180
17,000 New
17,000 $118,000

Others Institutions Holding RXDX

# of Institutions
2
Shares Held
29.6K
Call Options Held
0
Put Options Held
0
View Full List

About Prometheus Biosciences, Inc.

RXDX Quotes by TradingView
  • Ticker RXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,904,100
  • Description
  • Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...
More about RXDX
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email